Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you use bolus in patients s/p mastectomy and reconstruction if they had dermal involvement?
Answer from: Radiation Oncologist at Community Practice
Pathological dermis involvement is a risk factor of LR and I would use bolus for this situation.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
While we are increasingly omitting bolus, dermal involvement would concern me and I would use bolus.
Comments
Radiation Oncologist at University of Miami/Jackson Memorial Medical Center
Drs. @Sushil Beriwal and @Chirag S. Shah, would yo...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
I typically start with 1st 13 fractions and will m...
Radiation Oncologist at Indiana University Health
@Sushil Beriwal @Chirag S. Shah Would you consider...
9600
9602
15122
Sign in or Register to read more
11755
11772
Related Questions
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?
If a patient has multiple PET-avid level 3, supraclavicular, or IMN nodes that are small and would have been considered negative by size criteria with traditional imaging, that are no longer positive on PET after chemotherapy, would you try to boost these nodes?
Is DCISionRT appropriate for multifocal DCIS?
Under what circumstances would you pursue completion ALND in a patient with multiple positive sentinel nodes after breast-conserving surgery?
What are the advantages/disadvantages of using static IMRT vs VMAT when treating breast cancer?
For a young female (<40) with HR-/HER2+ cT1-2N1, ypT1aN0 s/p mastectomy with SLNB, would you offer PMRT?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?